EUR 25.05
(0.2%)
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2023 | 197.14 Million EUR | 4.25% |
2022 | 189.11 Million EUR | 7.65% |
2021 | 175.67 Million EUR | 11.55% |
2020 | 157.49 Million EUR | -24.58% |
2019 | 208.81 Million EUR | -64.05% |
2018 | 580.83 Million EUR | -2.54% |
2017 | 595.96 Million EUR | 5.12% |
2016 | 566.94 Million EUR | 50.53% |
2015 | 376.63 Million EUR | 21.25% |
2014 | 310.63 Million EUR | 9.11% |
2013 | 284.7 Million EUR | -1.52% |
2012 | 289.09 Million EUR | 88.79% |
2011 | 153.13 Million EUR | -39.66% |
2010 | 253.77 Million EUR | 0.16% |
2009 | 253.36 Million EUR | 1.83% |
2008 | 248.81 Million EUR | 5.75% |
2007 | 235.29 Million EUR | 5.5% |
2006 | 223.01 Million EUR | 9.83% |
2005 | 203.05 Million EUR | 3.28% |
2004 | 196.59 Million EUR | 0.0% |
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2024 Q2 | 338.76 Million EUR | 0.0% |
2023 FY | 197.14 Million EUR | 4.25% |
2023 Q2 | 23.7 Million EUR | 0.0% |
2023 Q4 | 290.29 Million EUR | 0.0% |
2022 FY | 189.11 Million EUR | 7.65% |
2022 Q4 | -42.78 Million EUR | 0.0% |
2022 Q2 | 22.75 Million EUR | 0.0% |
2021 Q4 | 17.26 Million EUR | 0.0% |
2021 Q2 | 39.56 Million EUR | 0.0% |
2021 FY | 175.67 Million EUR | 11.55% |
2020 Q4 | 22.48 Million EUR | 0.0% |
2020 Q2 | 23.13 Million EUR | 0.0% |
2020 FY | 157.49 Million EUR | -24.58% |
2019 Q4 | 31.63 Million EUR | 0.0% |
2019 Q2 | 38.65 Million EUR | 0.0% |
2019 FY | 208.81 Million EUR | -64.05% |
2018 Q4 | 266.65 Million EUR | 0.0% |
2018 Q2 | 314.17 Million EUR | 0.0% |
2018 FY | 580.83 Million EUR | -2.54% |
2017 FY | 595.96 Million EUR | 5.12% |
2017 Q2 | 312.33 Million EUR | 0.0% |
2017 Q4 | 283.63 Million EUR | 0.0% |
2016 FY | 566.94 Million EUR | 50.53% |
2016 Q2 | 296.13 Million EUR | 0.0% |
2016 Q4 | 270.81 Million EUR | 0.0% |
2015 Q4 | 191.76 Million EUR | 0.0% |
2015 Q2 | 184.87 Million EUR | 0.0% |
2015 FY | 376.63 Million EUR | 21.25% |
2014 FY | 310.63 Million EUR | 9.11% |
2014 Q4 | 154.17 Million EUR | 0.0% |
2014 Q2 | 156.46 Million EUR | 0.0% |
2013 Q2 | 146.61 Million EUR | 0.0% |
2013 Q4 | 138.09 Million EUR | 0.0% |
2013 FY | 284.7 Million EUR | -1.52% |
2012 Q1 | 72.27 Million EUR | 0.0% |
2012 FY | 289.09 Million EUR | 88.79% |
2012 Q4 | 73.26 Million EUR | 1.37% |
2012 Q3 | 72.27 Million EUR | 0.0% |
2012 Q2 | 72.27 Million EUR | 0.0% |
2011 FY | 153.13 Million EUR | -39.66% |
2011 Q3 | 38.28 Million EUR | 0.0% |
2011 Q1 | 38.28 Million EUR | 0.0% |
2011 Q2 | 38.28 Million EUR | 0.0% |
2011 Q4 | 72.27 Million EUR | 88.79% |
2010 Q1 | 63.44 Million EUR | 0.0% |
2010 Q3 | 63.44 Million EUR | 0.0% |
2010 FY | 253.77 Million EUR | 0.16% |
2010 Q4 | 38.28 Million EUR | -39.66% |
2010 Q2 | 63.44 Million EUR | 0.0% |
2009 Q3 | 63.34 Million EUR | 0.0% |
2009 Q1 | 63.34 Million EUR | 0.0% |
2009 FY | 253.36 Million EUR | 1.83% |
2009 Q4 | 63.44 Million EUR | 0.16% |
2009 Q2 | 63.34 Million EUR | 0.0% |
2008 Q3 | 62.2 Million EUR | 0.0% |
2008 Q2 | 62.2 Million EUR | 0.0% |
2008 Q1 | 62.2 Million EUR | 0.0% |
2008 FY | 248.81 Million EUR | 5.75% |
2008 Q4 | 63.34 Million EUR | 1.83% |
2007 Q4 | 62.2 Million EUR | 5.75% |
2007 Q3 | 58.82 Million EUR | 0.0% |
2007 Q2 | 58.82 Million EUR | 0.0% |
2007 Q1 | 58.82 Million EUR | 0.0% |
2007 FY | 235.29 Million EUR | 5.5% |
2006 Q1 | 55.75 Million EUR | 0.0% |
2006 FY | 223.01 Million EUR | 9.83% |
2006 Q3 | 55.75 Million EUR | 0.0% |
2006 Q2 | 55.75 Million EUR | 0.0% |
2006 Q4 | 58.82 Million EUR | 5.5% |
2005 Q1 | 50.76 Million EUR | 0.0% |
2005 Q4 | 55.75 Million EUR | 9.83% |
2005 Q3 | 50.76 Million EUR | 0.0% |
2005 Q2 | 50.76 Million EUR | 0.0% |
2005 FY | 203.05 Million EUR | 3.28% |
2004 FY | 196.59 Million EUR | 0.0% |
2004 Q2 | 49.14 Million EUR | 0.0% |
2004 Q1 | 49.14 Million EUR | 0.0% |
2004 Q3 | 49.14 Million EUR | 0.0% |
2004 Q4 | 50.76 Million EUR | 3.28% |
2003 Q4 | 49.14 Million EUR | 0.0% |
Name | Gross Profit | Gross Profit Difference |
---|---|---|
Affluent Medical SA | -1.2 Million EUR | 16528.917% |
Bluelinea Société Anonyme | -3.84 Million EUR | 5223.915% |
Carmat SA | -30.97 Million EUR | 736.554% |
Diagnostic Medical Systems S.A. | 15.84 Million EUR | -1144.379% |
Euromedis Groupe | 3.57 Million EUR | -5419.888% |
Eurobio Scientific Société anonyme | 53.96 Million EUR | -265.317% |
Ikonisys S.A. | 255.82 Thousand EUR | -76962.624% |
Implanet S.A. | 3.13 Million EUR | -6194.604% |
Median Technologies SA | -2.55 Million EUR | 7828.224% |
SpineGuard SA | 3.37 Million EUR | -5734.384% |
Theraclion SA | -1.08 Million EUR | 18347.847% |
Euroapi S.A. | 164.6 Million EUR | -19.773% |
Ion Beam Applications SA | 134.44 Million EUR | -46.642% |
Koninklijke Philips N.V. | 7.44 Billion EUR | 97.353% |
Sequana Medical NV | 548.04 Thousand EUR | -35872.513% |